Videos

After a cancer diagnosis, Maryland Governor Larry Hogan had to lean on family from both his personal and professional life to helping take on treatment and beat cancer twice.

Genetic testing is proving itself to be a vital tool in treating patients with prostate cancer but educating men on its importance also needs to take priority.

Hope for Stomach Cancer helps provide awareness for patients with stomach cancer and their caregivers.

“It really is an exciting time for patients with lymphoma, because the options are just really exploding at a very encouraging rate,” said Dr. Lori A. Leslie.

Dr. Toni K. Choueiri discusses what therapies are currently available for patients with metastatic renal cell carcinoma, as well as what new treatments could be on the horizon.

We answer your patient navigation questions at the 4th Annual Patient Navigation Town Hall "Empowering and Mobilizing Our Patient Navigation Workforce".

At the 4th Annual Patient Navigation Town Hall "Empowering and Mobilizing Our Patient Navigation Workforce", experts discuss how navigators can mobilize for equity in their field.

At the 4th Annual Patient Navigation Town Hall "Empowering and Mobilizing Our Patient Navigation Workforce", we provide you insight into how to get properly certified as a patient or nurse navigator.

The importance of nurse navigation and patient navigation through the COVID-19 pandemic.

On the Today Show, Scott Hamilton share's his cancer story and also gives a look at his book "Frtizy Finda A Hat", a children's book to help parents talk about cancer with their kids.

Dr. Parameswaran Hari discusses the importance of understanding a patient’s MRD if they are receiving the maintenance therapy Sarclisa for multiple myeloma.

Leading experts in the CLL landscape discuss the latest treatment options for patients and answer questions from the CURE audience.

There are some job protected options for patients with cancer, survivors and caregivers to consider when it comes to returning to work during the COVID-19 pandemic. But, as one cancer rights attorney notes, there are many challenges to those options.

The microorganisms inside a patient's gastrointestinal tract may have a role to play in how immunotherapy can treat certain types of cancer.

In an interview with CURE®, Dr. Jorge Gomez discussed how recent developments in the assessment of biomarkers within the small cell lung cancer and non-small cell lung cancer space have led to approvals of new and expanded therapies.

CURE® interviews Voices contributor Tamera Anderson-Hanna on the benefits of continuing to perform yoga at home for both patients with cancer experiencing lymphedema, as well as caregivers looking to address their own mental well-being.

On the importance of finding more potent and well-tolerated therapies in hepatocellular carcinoma, Dr. Bruno Sangro explains: “The wider the spectrum of choices, the better we will be able to treat our patients.”

Dr. Timothy Burns, of UPMC Hillman Cancer Center, discusses developments in the treatment of lung cancer over the next several years that have exciting potential to impact the field.

Dr. Julia Rani Nangia explains how certain chemotherapy types and sequencing have different impacts on hair retention for patients with breast cancer.

Hair loss is a common side effect in treatment for cancer, but for patients looking to manage it Dr. Julie Rani Nangia breaks down how scalp cooling can slow down hair loss.

“When time passes, and you look back it seems like a distant memory.”

“One FDA approval that we were quite excited about (is Tabrecta). And I've actually already put some patients on it; it's a very good drug,” Dr. Timothy Burns said in a recent interview.

“At 34, I have another chance to live the rest of my life with a consciousness that there's great purpose in the pain.”

“You have to speak up. What you don’t say is the most predictive of the care you don’t get.”

“There's a lot of miscommunication and number one, I would tell them you don't need to face these decisions alone,” Dr. Pat Basu said in an interview addressing patient’s fear in the midst of the COVID-19 pandemic.

The recent surge of drug approvals in the non-small cell lung cancer (NSCLC) space by the Food and Drug Administration (FDA) is quite unusual and only a fraction of them are considered practice changing, according to Dr. Timothy Burns.

An expert explains the importance of the fourth approval of the immunotherapy Tecentriq for certain patients with metastatic non-small cell lung cancer who have a high PD-L1 expression.

“We don't know what the best treatment paradigm is for a patient whose disease is most clearly manifest on a PSMA scan as opposed to standard imaging,” said Dr. Michael J. Morris. “All that work has yet to be done, and we can only do it once we have the scan available to us as a tool in the United States.”

The impact of the COVID-19 pandemic on the cancer landscape has lead to enormous challenges for patients and professionals alike, but the impact of the pandemic will be felt on cancer care for years to come.

“If I only have one tool to treat the disease, I will play with that tool in many different ways. But if I have access to four different tools, then I will give up tool (number) one if I don't feel it's working,” explained Dr. Mazyar Shadman of the Seattle Cancer Care Alliance, about his approach to treating high-risk chronic lymphocytic leukemia in an interview with CURE®.